Latest News
The key guide to estimating hazard ratios from published data gets a major update
Comprehensively updated guidance and associated calculations spreadsheet are valuable new tools for all those conducting meta-analyses based on published time-to-event data.
New guidance on addressing barriers to sharing trial results with participants
The new guidance summarises the discussion from a workshop for trial funders, and signposts relevant resources and guidance.
The STAMPEDE prostate cancer trial wins NIHR Impact Prize
The NIHR Impact Awards celebrate research that has had an outstanding impact beyond academia.
STOPCAP study finds that most men with advanced prostate cancer benefit from new-generation hormone therapy drugs
New results from a meta-analysis by the STOPCAP Collaboration were presented at the American Society of Clinical Oncology Genitourinary 2025 Meeting.
SMAART-MAP malaria trial opens for recruitment
SMAART-MAP is a platform trial testing supportive treatments added to standard treatment. The trial aims to improve short-term recovery in children hospitalised with severe malaria.